Results 71 to 80 of about 82,830 (185)

Blood Level of Tacrolimus in Patients with Severe Allergic Conjunctivitis Treated by 0.1% Tacrolimus Ophthalmic Suspension [PDF]

, 2012
BackgroundTo estimate the efficacy and safety of 0.1% tacrolimus ophthalmic suspension based on the blood level of tacrolimus in patients with severe allergic conjunctivitis.MethodsFifty-two patients in whom topical anti-allergic agents had been ...
Fujishima, Hiroshi, Fukushima, Atsuki, Jun Shoji, Yayoi Nakagawa, Nobuyuki Ebihara, Uchio, Eiichi, Etsuko Takamura, Shoji, Jun, Dai Miyazaki, Miyazaki, Dai, Ohashi, Yuichi, Yuichi Ohashi, Namba, Kenichi, Okamoto, Shigeki, Hiroshi Fujishima, Ebihara, Nobuyuki, Takamura, Etsuko, Shigeki Okamoto, Kenichi Namba, Atsuki Fukushima, Eiichi Uchio, Nakagawa, Yayoi   +21 more
core   +1 more source

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients

Pharmacogenomics and Personalized Medicine, 2021
Fang Cheng,1,2 Qiang Li,1,2 Jinglin Wang,1,2 Min Hu,1,2 Fang Zeng,1,2 Zhendi Wang,3 Yu Zhang1,2 1Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People’s Republic of China ...
Cheng F, Li Q, Wang J, Hu M, Zeng F, Wang Z, Zhang Y   +6 more
doaj  

Tacrolimus induced reversible encephalopathy [PDF]

, 2013
Tacrolimus is a novel immunosuppressant used to prevent graft rejection after allogenic organ transplantation. Serious neurological complications of tacrolimus are rare.
Surya, Nirmal, Visana, Devshi
core  

Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients

, 2010
P Dalal1, G Shah1, D Chhabra2, Lorenzo Gallon21Department of Medicine, Mount Sinai Hospital, Chicago; 2Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USAIntroduction: Several new medications are now available for ...
P Dalal, D Chhabra, G Shah, et al
core  

Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-Year observational results [PDF]

, 2015
The European Tacrolimus versus Ciclosporin-A Microemulsion (CsA-ME) Renal Transplantation Study demonstrated that tacrolimus decreased acute rejection rates at 6 months.
European Tacrolimus versus Ciclosporin Microemulsion Renal Transplantation Study, Krüger, Bernd, Kunzendorf, Ulrich, Krämer, Bernhard K, Marcen, Roberto, RONCO, CLAUDIO, Arias, Manuel, Krämer, Bernhard K., Mühlbacher, Ferdinand, Hörsch, Silke, Banas, Bernhard, Margreiter, Raimund, Sester, Urban, RIGOTTI, PAOLO, Dietl, Karl-Heinz, Dietl, Karl Heinz, Montagnino, Giuseppe, Olbricht, Christoph J, Olbricht, Christoph J.   +18 more
core   +1 more source

Drug-drug interaction between diltiazem and tacrolimus in relation to CYP3A5 genotype status in Chinese pediatric patients with nephrotic range proteinuria: a retrospective study

Frontiers in Pharmacology
BackgroundTacrolimus is widely used to treat pediatric nephrotic range proteinuria (NRP). Diltiazem, a CYP3A4/5 inhibitor, is often administered with tacrolimus, affecting its pharmacokinetic profile. The impact of this combination on tacrolimus exposure,
Qiaoling Yang, Qiaoling Yang, Yan Wang, Yan Wang, Xuebin Wang, Ping Wang, Boyu Tan, Yijun Li, Huajun Sun, Wenyan Huang, Hongxia Liu   +10 more
doaj   +1 more source

Tacrolimus for the management of psoriasis: clinical utility and place in therapy

, 2016
Nina Malecic,1,2 Helen Young2 1Manchester Medical School, 2The Dermatology Research Centre, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK Abstract: Psoriasis affects 1%–3% of the population in the United ...
Malecic N, Young H
core  

A Case Report of Living-Related Renal Transplantation Accompanied by Complications Induced by Calcineurin Inhibitors [PDF]

, 2003
A 19-year-old woman received an ABO-compatible living-related renal transplant whose donor was her　46-year-old mother (HLA A, B 2 match, DR 2 match), on December 9, 1999.
樋口, 誠, 出浦, 正, 重松, 秀一, 清澤, 研道, 徳永, 真一   +4 more
core  

Model‐Based Tacrolimus Dosing Using the Population Pharmacokinetic Analysis Under the Nirmatrelvir/Ritonavir Therapy

CPT: Pharmacometrics & Systems Pharmacology
Nirmatrelvir/ritonavir is an antiviral agent used against severe acute respiratory syndrome coronavirus 2 infection and inhibits cytochrome P450 3A and P‐glycoprotein.
Kotaro Itohara, Yoshiki Katada, Takahiro Hatayama, Toshiaki Igarashi, Jiro Ogura, Tomoki Fukushima, Shingo Yamazaki, Masato Homma, Takashi Niwa, Yoshiaki Kato, Nanae Yamamoto, Hideyuki Terazono, Hideo Shiohira, Tomohiro Terada, Ikuko Yano   +14 more
doaj   +1 more source

Clinical Evaluation of the Efficacy and Safety of Co-Administration of Wuzhi Capsule and Tacrolimus in Adult Chinese Patients with Myasthenia Gravis

Neuropsychiatric Disease and Treatment, 2021
Yuyao Peng, Fei Jiang, Ran Zhou, Wanlin Jin, Yi Li, Weiwei Duan, Liqun Xu, Huan Yang Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, People’s Republic of ChinaCorrespondence: Liqun Xu; Huan YangDepartment of ...
Peng Y, Jiang F, Zhou R, Jin W, Li Y, Duan W, Xu L, Yang H   +7 more
doaj